University of Tokyo and Keio University joined multiple corporates in a round that brought the pre-clinical drug developer's funding haul to $33.1m.

Japan-based drug developer Modulus Discovery completed a ¥2.7bn ($25.2m) series B round yesterday featuring UTokyo Innovation Platform and Keio Innovation Initiative, investing for University of Tokyo and Keio University, respectively. SBI Investments, Mizuho Capital and SMBC Venture Capital – investing on behalf of financial services firms SBI Holdings, Mizuho Bank and Sumitomo Mitsui Banking Corporation…

The rest of this content is only accessible to Global University Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.